Before the four astronauts of the Artemis II mission launch into space, the crew must complete NASA's two-week Health ...

KKR, Hamilton Lane, Morgan Stanley Capital Partners, Kohlberg and Blackstone are among the firms investing in data ...

Disc Medicine’s leadership tried to express optimism that its rare disease therapy bitopertin can be approved based on a Phase 3 trial set to begin shortly. However, analysts are worried that the ...

This is a step, if presently halting, toward future lunar missions and a long-term human presence on our companion world, one so important that even SpaceX is setting aside Mars for a greater focus on ...

EaglePicher Technologies, which has been a part of space exploration since its earliest days, is going back soon as part of the Artemis moon missions. “It’s exciting because we were there when NASA ...

In the coming weeks, Artemis II will send humans around the moon for the first time in more than 50 years. Could it be a redemptive moment, as it was in 1968?

There are good reasons for private-equity bosses to downplay the importance of a business that made them rich. The biggest ...

The Artemis II mission, which will return US astronauts to lunar space, has run into problems that have critics demanding NASA remove the crew from the flight for safety reasons. The bigger question ...

A test of NASA's towering Space Launch System rocket uncovered another issue with the vehicle meant to launch astronauts on a ...

Former U.S. President Ronald Reagan famously said that the nine scariest words in the English language are, “I'm from the ...

Last time in action: Rhiyo defeated Giulia and Kiana James (SD, Feb. 6), Legend and Jax lost to Giulia and James (SD, Jan. 23 ...

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...